Electronic Processing of Antimicrobial Susceptibilities to Enhance Communicable Disease Surveillance

The emerging threat of antimicrobial resistant organisms is a pressing public health concern. Surveillance for antimicrobial resistance can prevent infections, protect patients in the healthcare setting and improve antimicrobial use. In 2018, the Utah Department of Health mandated the reporting of antimicrobial susceptibility panels performed on selected organisms. Utah utilizes the Electronic Message Staging Area (EMSA), a home-grown application to translate, process, and enter electronic laboratory results into UT-NEDSS, Utah'™s integrated disease surveillance system.

June 18, 2019

Automating Antimicrobial Usage Reporting

Antimicrobial stewardship is crucial to the ongoing viability of existing therapies. To facilitate this stewardship, NHSN allows hospitals to submit data on their antimicrobial usage and receive feedback on how their usage compares to other facilities.1 This feedback can be used by hospital personnel to assess whether their antimicrobial policies are consistent with current best practices. Participation in this program has so far been limited.

June 18, 2019

A Tool for Promoting Responsible Antibiotic Prescribing across Settings and Sectors

Antibiotic resistance is a mounting public health threat calling for action on global, national and local levels. Antibiotic use has been a major driver of increasing rates of antibiotic resistance. This has given rise to the practice of antibiotic stewardship, which seeks to reduce unnecessary antibiotic use across different care settings. Antibiotic stewardship has been increasingly applied in hospital settings, but adoption has been slow in many ambulatory care settings including primary care of humans. Uptake of antibiotic stewardship in veterinary care has been similarly limited.

June 18, 2019

Tracking harmful chemicals and pathogens using the Human Health Observatory at ASU

Sewerage systems of villages, townships, cities and megacities convey the urine, stool, blood, and sputum of community members, enabling through analysis of community wastewater, a near real-time assessment of population health status and of emerging public health threats. Signature compounds and biomarkers targeted analytically for surveillance may include chemical and biological threat agents, transformation products of the same, human metabolites, biomarkers of exposure and other markers of interest.

June 18, 2019

Anti-microbial Resistance surveillance in typhoidal Salmonella in Ahmedabad

India carries the highest burden of Enteric Fever in the world. This is further aggravated by the high prevalence of antimicrobial resistance (AMR) in typhoidal Salmonellae. The strategy to combat resistance has been to combine and cycle anti-microbials based on the regional AMR pattern of the organism. But this requires that resistance patterns and genetic mechanisms are mapped at a regional level and regularly recorded and disseminated by a national surveillance system.

June 18, 2019

Data Model for Initiatives to Monitor Exposure to Antimicrobials (DataMIME)

Despite decades of attempts to promote judicious AU, the US has high rates of per-person antimicrobial consumption, and extremely high rates of carbapenem use. Such profligate use is a key factor in the high rate of antimicrobial-resistant infections seen in US healthcare facilities. Antimicrobial stewardship (AS) programs have been identified as a critical component of intervention strategies.

January 21, 2018

Antibiotic Resistance Investment Map

The AR Investment Map showcases the Centers for Disease Control & Prevention's (CDC) activities to meet national goals to prevent drug-resistant infections. CDC’s AR Solutions Initiative puts state and local AR laboratory and epidemiological expertise in every state and makes investments in public health innovation to fight AR across healthcare settings, food, and communities.

March 29, 2018

Carbapenem Resistant Enterobacteriaceae infections in Houston, Texas: An outline

According to CDC, CRE is used to describe bacteria that are nonsusceptible to one or more carbapenems; doripenem, meropenem or imipenem and resistant to third generation cephalosporins like ceftriaxone, cefotaxime and ceftazidime. These organisms cause infections that are associated with high mortality rates and they have the potential to spread widely. Antibiotic resistant bacteria cause more than 2 million illnesses and at least 23,000 deaths each year in United States.

December 15, 2016

CIPARS: A One-Health Approach to Antimicrobial Resistance Surveillance

AMR has been identified as a global threat to public health. Resistant bacteria and associated genes can move within and between populations of people and animals, making AMR a very complex and contentious issue. Credible, multi-sectoral surveillance data provide information to promote prudent AMU in hospitals, the community, and agriculture.

Objective

October 10, 2017

Antibiotic Susceptibility of Salmonellosis Pathogens

It is increasingly critical to test antibiotics on local bacterial strains, due to the continuously growing resistance of microflora to extensively administered antibacterial medications. For this study, we examined the development of antimicrobial resistance of Salmonellae collected in Uzbekistan through 1998 versus those collected in 2008.

Objective

We tested local bacterial strains' resistance to antibiotics at both a broad selection and range of commercial preparations.

August 22, 2018

Pages

Contact Us

NSSP Community of Practice

Email: syndromic@cste.org

 

This website is supported by Cooperative Agreement # 6NU38OT000297-02-01 Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health between the Centers for Disease Control and Prevention (CDC) and the Council of State and Territorial Epidemiologists. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC. CDC is not responsible for Section 508 compliance (accessibility) on private websites.

Site created by Fusani Applications